Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

1.5K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.5K
Myasthenia Gravis: Diagnostic Tests01:15

Myasthenia Gravis: Diagnostic Tests

924
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
924
Chronic Pancreatitis I: Introduction01:24

Chronic Pancreatitis I: Introduction

95
The pancreas, an elongated and flat gland situated behind the stomach, serves a vital function in digesting food and managing blood sugar levels.
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
95
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

957
Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
957
Disorders of the Nervous Tissue01:28

Disorders of the Nervous Tissue

1.4K
Nervous tissue is a vital component of the human body's communication system, enabling us to perceive and respond to stimuli. However, like all other tissues, it is vulnerable to disorders and diseases that can significantly impact our neurological functioning.
Homeostatic Imbalances:
Alzheimer's disease manifests as a gradual decline in memory and cognitive abilities, attributed to the buildup of amyloid plaques and neurofibrillary tangles in the brain.
Parkinson's disease arises from the...
1.4K
Autoimmune Disorders01:29

Autoimmune Disorders

456
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
456

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Consensus Definitions of Disease Activity and Clinical Outcomes in Patients With Chronic Inflammatory Demyelinating Polyradiculoneuropathy.

Neurology·2026
Same author

Incidence, Prevalence, and Treatment Patterns in Chronic Inflammatory Demyelinating Polyneuropathy: Data Analysis of US Claims.

Neuroepidemiology·2026
Same author

The Neuromuscular Portal and Match: Working Toward a More Fair, Equitable, and Transparent Process.

Neurology. Education·2024
Same author

Effect of Ezogabine on Cortical and Spinal Motor Neuron Excitability in Amyotrophic Lateral Sclerosis: A Randomized Clinical Trial.

JAMA neurology·2020
Same author

Inhibition of the transcription factor ROR-γ reduces pathogenic Th17 cells in acetylcholine receptor antibody positive myasthenia gravis.

Experimental neurology·2019
Same author

Validation of a simple disease-specific, quality-of-life measure for diabetic polyneuropathy: CAPPRI.

Neurology·2018

Related Experiment Video

Updated: Jul 13, 2025

Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination
09:38

Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination

Published on: September 12, 2016

12.3K

Chronic Immune-Mediated Demyelinating Neuropathies.

Karissa Gable

    Continuum (Minneapolis, Minn.)
    |October 18, 2023
    PubMed
    Summary

    This review covers chronic demyelinating neuropathies, focusing on immune-mediated types. Early diagnosis and differentiation are crucial for effective treatment and improved prognosis in these complex neurological disorders.

    Area of Science:

    • Neurology
    • Immunology
    • Clinical Neuroscience

    Background:

    • Chronic demyelinating neuropathies (CDNs) encompass a heterogeneous group of disorders.
    • Immune-mediated mechanisms, involving both humoral and cellular responses, are central to specific CDNs.
    • Differentiating CDNs is challenging due to overlapping clinical presentations.

    Purpose of the Study:

    • To provide an overview of CDNs, emphasizing immune-mediated neuropathies.
    • To discuss phenotypic categorization, diagnostic approaches, and treatment strategies for CDNs.
    • To highlight mimics of immune-mediated neuropathies and differentiate them from primary demyelinating conditions.

    Main Methods:

    • Review of current literature on chronic demyelinating neuropathies.
    • Discussion of diagnostic criteria and clinical characteristics.

    More Related Videos

    A Simple Approach to Induce Experimental Autoimmune Neuritis in C57BL/6 Mice for Functional and Neuropathological Assessments
    07:30

    A Simple Approach to Induce Experimental Autoimmune Neuritis in C57BL/6 Mice for Functional and Neuropathological Assessments

    Published on: November 9, 2017

    9.4K
    Induction of Paralysis and Visual System Injury in Mice by T Cells Specific for Neuromyelitis Optica Autoantigen Aquaporin-4
    09:29

    Induction of Paralysis and Visual System Injury in Mice by T Cells Specific for Neuromyelitis Optica Autoantigen Aquaporin-4

    Published on: August 21, 2017

    11.5K

    Related Experiment Videos

    Last Updated: Jul 13, 2025

    Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination
    09:38

    Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination

    Published on: September 12, 2016

    12.3K
    A Simple Approach to Induce Experimental Autoimmune Neuritis in C57BL/6 Mice for Functional and Neuropathological Assessments
    07:30

    A Simple Approach to Induce Experimental Autoimmune Neuritis in C57BL/6 Mice for Functional and Neuropathological Assessments

    Published on: November 9, 2017

    9.4K
    Induction of Paralysis and Visual System Injury in Mice by T Cells Specific for Neuromyelitis Optica Autoantigen Aquaporin-4
    09:29

    Induction of Paralysis and Visual System Injury in Mice by T Cells Specific for Neuromyelitis Optica Autoantigen Aquaporin-4

    Published on: August 21, 2017

    11.5K
  • Emphasis on distinguishing immune-mediated neuropathies from other demyelinating conditions.

    • Main Results:

    • Recent advances include the identification of antibody-mediated antinodal and paranodal demyelinating neuropathies.
    • New diagnostic criteria are emerging for certain CDNs.
    • Understanding pathophysiology aids in differentiating various forms of chronic demyelinating polyneuropathy.

    Conclusions:

    • Accurate diagnosis and classification of CDNs are essential for appropriate management.
    • Distinguishing between immune-mediated and other CDNs impacts treatment decisions and patient outcomes.
    • Continued research into pathophysiology and diagnostic markers will improve patient care for chronic demyelinating neuropathies.